As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease.
|Articles|July 17, 2012
Deciding On Truvada: Who Should Take A HIV Prevention Pill?
Advertisement
There's something new to prevent HIV infections.
The Food and Drug Administration on Monday approved a once-a-day pill that can drastically lower a person's risk of getting the virus that causes AIDS.
It's called Truvada — the first HIV prevention pill.
Read the full story:
Source: NPR
Advertisement
Related to this article
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Speakers at ASN Kidney Week urge nephrologists to appeal prior authorization denials, include children in trials, and expand access to glomerular disease therapies globally.
ASN Kidney Week 2026 experts discussed GLP-1 RAs alongside lifestyle care, global access, and bariatric surgery for obesity in chronic kidney disease.
Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
Advertisement
Advertisement
Trending on AJMC
1
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
2
UPMC Health Plan's Food as Medicine Pilot for Members With Diabetes
3
Real-World AMKD Data Highlight Quick Progression, Unmet Needs
4
Pulmonary Embolism Can Affect Elite Athletes, Too: Samantha Pettigrew, MD
5